| 37729615 | CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216. | Blood Adv | 2024 |
| 36384252 | Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia. | Haematologica | 2023 |
| 37715727 | An SRF-rearranged malignant cellular myoid neoplasm with a novel SRF-MKL2 fusion. | Pediatr Blood Cancer | 2023 |
| 37419244 | Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors. | J Mol Diagn | 2023 |
| 36946317 | <i>IL16</i> and factor V gene variations are associated with asparaginase-related thrombosis in childhood acute lymphoblastic leukemia patients. | Pharmacogenomics | 2023 |
| 37407142 | Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial. | Lancet Haematol | 2023 |
| 37261858 | Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia. | J Natl Cancer Inst | 2023 |
| 36921036 | A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis. | Sci Transl Med | 2023 |
| 36825687 | Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed). | Pediatr Hematol Oncol | 2023 |
| 35989471 | Update: Clinical characteristics and outcomes of SARS-CoV-2 infection in pediatric oncology patients in the province of Quebec. | Pediatr Blood Cancer | 2023 |
| 33197607 | The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. | Semin Cancer Biol | 2022 |
| 36485164 | Clinical screening for Ph-like ALL and the developing role of TKIs. | Hematology Am Soc Hematol Educ Program | 2022 |
| 36555978 | COVID-19 and Sickle Cell Disease in the Province of Quebec, Canada: Outcomes after Two Years of the Pandemic. | J Clin Med | 2022 |
| 36103644 | Durable Response to Trametinib in an Infant With <i>ERC1-BRAF</i> Infantile Fibrosarcoma-Like Tumor: A Case Report and Literature Review of <i>BRAF</i>-Altered Infantile Fibrosarcoma-Like Tumors. | JCO Precis Oncol | 2022 |
| 36069432 | Feasibility of oncology clinical trial-embedded evaluation of social determinants of health. | Pediatr Blood Cancer | 2022 |
| 36067507 | Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C. | Leuk Lymphoma | 2022 |
| 35876545 | Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic data. | Pediatr Blood Cancer | 2022 |
| 34933343 | Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. | Blood Adv | 2022 |
| 35084108 | Clinical characteristics and outcomes of SARS-CoV-2 infection in pediatric oncology patients in the province of Quebec. | Pediatr Blood Cancer | 2022 |
| 32970927 | Comment on: Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19. | Pediatr Blood Cancer | 2021 |
| 33626861 | The <i>EBF1-PDGFRB</i> T681I mutation is highly resistant to imatinib and dasatinib <i>in vitro</i> and detectable in clinical samples prior to treatment. | Haematologica | 2021 |
| 34865703 | Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype? | Best Pract Res Clin Haematol | 2021 |
| 34011251 | Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia. | Expert Opin Pharmacother | 2021 |
| 34198115 | Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols. | Leuk Res | 2021 |
| 31515871 | Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia. | Genes Chromosomes Cancer | 2020 |
| 33035991 | High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study. | Eur J Cancer | 2020 |
| 32611574 | ABL-class fusion positive acute lymphoblastic leukemia: can targeting ABL cure ALL? | Haematologica | 2020 |
| 32245541 | IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly. | Blood Rev | 2020 |
| 32372697 | HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium. | Pharmacogenomics | 2020 |
| 31026031 | Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers. | JAMA Netw Open | 2019 |
| 29284681 | A novel <i>AGGF1-PDGFRb</i> fusion in pediatric T-cell acute lymphoblastic leukemia. | Haematologica | 2018 |
| 30502852 | Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options. | Semin Hematol | 2018 |
| 29507076 | Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia. | Blood Adv | 2018 |
| 28600472 | Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies. | Clin Cancer Res | 2017 |
| 28408464 | Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. | Blood | 2017 |
| 27913529 | Ph-like acute lymphoblastic leukemia. | Hematology Am Soc Hematol Educ Program | 2016 |
| 25155014 | Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: a systematic review. | BMC Cancer | 2014 |
| 26625386 | Second Bacteremia During Antibiotic Treatment in Children With Acute Myeloid Leukemia: A Report From the Canadian Infections in Acute Myeloid Leukemia Research Group. | J Pediatric Infect Dis Soc | 2014 |
| 23392364 | Coagulation assessment in children with diabetic ketoacidosis. | Pediatr Crit Care Med | 2013 |
| 24289042 | Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group. | Infect Agent Cancer | 2013 |
| 25077103 | Salmonella enterica serotype Typhi infections in a Canadian pediatric hospital: a retrospective case series. | CMAJ Open | 2013 |